Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts…
© Reuters. FDA converts Biogen and Eisai's Alzheimer's treatment to traditional approval
The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi (lecanemab-irmb), a treatment for adult patients with…